Ticker Details
Oric Pharmaceuticals, Inc.
IPO Date:	April 24, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.08B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.46 | 3.61%
Avg Daily Range (30 D):	$0.46 | 4.27%
Avg Daily Range (90 D):	$0.35 | 3.18%

Institutional Daily Volume
Avg Daily Volume:	.45M
Avg Daily Volume (30 D):	1.44M
Avg Daily Volume (90 D):	1.19M

Trade Size
Avg Trade Size (Sh.):	85
Avg Trade Size (Sh.) (30 D):	87
Avg Trade Size (Sh.) (90 D):	77

Institutional Trades
Total Institutional Trades:	1,040
Avg Institutional Trade:	$1.6M
Avg Institutional Trade (30 D):	$1.77M
Avg Institutional Trade (90 D):	$1.67M
Avg Institutional Trade Volume:	.14M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.8M
Avg Closing Trade (30 D):	$2.29M
Avg Closing Trade (90 D):	$2.1M
Avg Closing Volume:	156.15K

News

Jan 14, 2026 @ 3:52 PM Precision Killers: Why Big Pharma is Betting Billi... Source: Prnewswire

Dec 6, 2025 @ 1:00 AM ORIC® Pharmaceuticals Presents Potential Best-i... Source: Oric Pharmaceuticals

Dec 5, 2025 @ 2:45 AM ORIC® Pharmaceuticals Presents Potential Best-i... Source: Oric Pharmaceuticals

Nov 6, 2025 @ 9:00 PM ORIC® Pharmaceuticals Announces Publication in ... Source: Oric Pharmaceuticals

Jun 6, 2025 @ 8:30 PM ORIC Pharmaceuticals Reports Inducement Grants und... Source: Oric Pharmaceuticals, Inc.

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-.33	$-.47	$-.42
Diluted EPS	$-.33	$-.47	$-.42
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-32.59M	$-36.36M	$-30.02M
Operating Income / Loss	$-36.67M	$-39.06M	$-32.72M
Cost of Revenue
Net Cash Flow	$-26.2M	$26.53M	$-10.07M
PE Ratio